Page 139 - NobleCon21

P3 Health Partners Inc.

SELECTED FINANCIAL ITEMS PIII
(in millions of USD)
CQ4 '24 CQ1 '25 CQ2 '25 CQ3 '25 LTM
Income Statement Key Items
Total Revenue 370.69 373.23 355.79 345.25 1,444.95
Gross Profit (39.54) 1.18 4.44 (24.54) (58.45)
Gross Margin -11% 0% 1% -7% -4%
EBIT (130.45) (38.09) (34.12) (44.22) (246.88)
EBIT Margin -35% -10% -10% -13% -17%
Net Income to Common Shareholders (129.15) (44.25) (43.67) (69.46) (286.52)
Net Margin -35% -12% -12% -20% -20%

Balance Sheet Key Items
Total Assets 783.42 783.87 731.59 683.56 683.56
Cash & Short Term Investments 38.82 40.08 38.58 37.71 37.71
% of Assets 5% 5% 5% 6% 6%
Current Assets -Total 184.14 191.44 156.53 135.63 135.63
% of Assets 24% 24% 21% 20% 20%
Total Liabilities 633.89 662.79 644.41 664.64 664.64
% of Assets 81% 85% 88% 97% 97%
Current Liabilities - Total 496.42 507.03 505.00 423.95 423.95
% of Assets 63% 65% 69% 62% 62%
Long Term Debt 89.82 106.12 101.96 214.18 214.18
% of Assets 11% 14% 14% 31% 31%
Total Equity 149.53 121.08 87.18 18.93 18.93
% of Assets 19% 15% 12% 3% 3%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities (57.24) (33.47) (16.63) (15.41) (122.75)
Net Cash Flow - Investing (0.48) NA 0.05 (0.12) (0.54)
Net Cash Flow - Financing 33.72 30.66 14.62 14.67 93.66

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Twenty-First Annual Emerging Growth Equity Conference